المؤلفون: Christian U. Blank, Rodabe N. Amaria, Jennifer A. Wargo, Bart A. van de Wiel, Georgina V. Long, Hussein Abdul-Hassan Tawbi, Alexander C. Huang, Xiaowei Xu, Richard A. Scolyer, Tara C. Mitchell, Giorgos C. Karakousis, Alexander C.J. van Akkooi, Michael A. Davies, Andrew J. Spillane, Elisa A. Rozeman, Alexander M. Menzies, Robyn P. M. Saw, Michael T. Tetzlaff, Ahmad A. Tarhini, Thomas E. Pennington, Elizabeth M. Burton, Paolo A. Ascierto, Serigne Lo

المصدر: Nature Medicine. 27:301-309

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Surrogate endpoint, Melanoma, medicine.medical_treatment, Ipilimumab, General Medicine, Immunotherapy, medicine.disease, General Biochemistry, Genetics and Molecular Biology, Targeted therapy, Clinical trial, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Nivolumab, business, Neoadjuvant therapy, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::826ffd3ff8235e1e6c027f5367069a0cTest
https://doi.org/10.1038/s41591-020-01188-3Test

المؤلفون: A.C.J. van Akkooi, Judith M. Versluis, Christian U. Blank, Charlotte L. Zuur, Elisa A. Rozeman, Willem M.C. Klop, Esmée P. Hoefsmit, Lindsay G Grijpink-Ongering, María Jesús González González, Sandra Adriaansz, Robyn P. M. Saw, Sydney Ch'ng, Sten Cornelissen, J Stretch, Annegien Broeks, Ton N. Schumacher, A A Torres Acosta, Hanna Eriksson, Ron M. Kerkhoven, B.A. van de Wiel, Petros Dimitriadis, Richard A. Scolyer, Oscar Krijgsman, Daniel S. Peeper, J.B.A.G. Haanen, Omgo E. Nieweg, Karolina Sikorska, Kerwin F. Shannon, Georgina V. Long, W.J. van Houdt, A.M. Menzies, H. Mallo, Irene L.M. Reijers, Andrew J. Spillane

المصدر: Nature Medicine. 27:256-263

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Melanoma, Phases of clinical research, Ipilimumab, General Medicine, medicine.disease, General Biochemistry, Genetics and Molecular Biology, law.invention, Clinical trial, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Randomized controlled trial, law, 030220 oncology & carcinogenesis, Internal medicine, medicine, Adjuvant therapy, Biomarker (medicine), Nivolumab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::391917477f238f400900eee0200e3f22Test
https://doi.org/10.1038/s41591-020-01211-7Test

المؤلفون: Maurits L. van Montfoort, Daniel J. Vis, Kees Hendricksen, Nick van Dijk, Laura A. Smit, Michiel S. van der Heijden, Henk G. van der Poel, Maries van den Broek, Christian U. Blank, Annemarie Bruining, Yoni Lubeck, Lodewyk F. A. Wessels, Dennis Peters, Pia Kvistborg, Karina Silina, Ton N. Schumacher, Charlotte van Rooijen, Karolina Sikorska, Erik Hooijberg, Annegien Broeks, Bas W.G. van Rhijn, Alberto Gil-Jimenez, Jeantine M de Feijter, Thierry N. Boellaard

المساهمون: University of Zurich, van der Heijden, Michiel S, Graduate School

المصدر: Nature medicine, 26(12), 1839-1844. Nature Publishing Group

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, medicine.medical_treatment, Programmed Cell Death 1 Receptor, 610 Medicine & health, Ipilimumab, 10263 Institute of Experimental Immunology, Gastroenterology, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, 1300 General Biochemistry, Genetics and Molecular Biology, Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Humans, Medicine, CTLA-4 Antigen, Stage (cooking), Adverse effect, Aged, Neoplasm Staging, business.industry, Antibodies, Monoclonal, General Medicine, Immunotherapy, Middle Aged, Clinical trial, Nivolumab, 030104 developmental biology, 030220 oncology & carcinogenesis, Monoclonal, 570 Life sciences, biology, Female, Urothelium, business, medicine.drug

وصف الملف: 2020_van_Dijk_Nat_Med.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0413d513e2c90df2d190163c39a4236dTest
http://www.scopus.com/inward/record.url?scp=85092396181&partnerID=8YFLogxKTest

المؤلفون: Christian U. Blank, Roger S. Lo, Magdalena Thurin, Claus Garbe, Sanjiv S. Agarwala, Sandra Demaria, Iman Osman, Richard D. Carvajal, Ryan J. Sullivan, Thomas F. Gajewski, Giorgio Trinchieri, Hassane M. Zarour, Georgina V. Long, Marc S. Ernstoff, Igor Puzanov, Paolo A. Ascierto, Jason J. Luke, Reinhard Dummer, Michael A. Postow, Corrado Caracò, Bernard A. Fox, Soldano Ferrone, Janis M. Taube, Patrick Hwu

المصدر: Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-22 (2020)
Journal of Translational Medicine

مصطلحات موضوعية: BRAF inhibitor, 0301 basic medicine, Oncology, medicine.medical_specialty, Electrochemotherapy, medicine.medical_treatment, lcsh:Medicine, Meeting Report, Anti-CTLA-4, Target therapy, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Tumor Microenvironment, medicine, Adjuvant therapy, Humans, CTLA-4 Antigen, Melanoma, Adjuvant, Combination strategies, MEK inhibitor, Tumor microenvironment, business.industry, lcsh:R, General Medicine, Immunotherapy, medicine.disease, Combined Modality Therapy, Anti-PD-1, CAR-T, Radiation therapy, 030104 developmental biology, Italy, 030220 oncology & carcinogenesis, Neoadjuvant, business, Biomarkers

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262f60d640e699b9c9d97a5cc4583ea7Test
http://link.springer.com/article/10.1186/s12967-020-02482-xTest

المؤلفون: Michael Millward, V. Atkinson, Sandip Pravin Patel, Christoph Hoeller, Christian U. Blank, Andrew Haydon, Alexander N. Shoushtari, Reinhard Dummer, Alexander M. Menzies, James Larkin, Carina N. Owen, Arissa Young, Maartje W. Rohaan, Dharmisha Chauhan, Shahneen Sandhu, Douglas B. Johnson, J. Mangana, Georgina V. Long, D. Palmieri, Matteo S. Carlino, Serigne Lo, Muhammad A. Khattak, Farzana Y Zaman, Peter Hersey, Belinda Lee

المصدر: Ann Oncol

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Ipilimumab, Gastroenterology, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Adjuvant therapy, Humans, Stage (cooking), Melanoma, Hematology, business.industry, Mucosal melanoma, medicine.disease, Combined Modality Therapy, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cutaneous melanoma, Immunotherapy, business, Adjuvant, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b83e339b674f679f965aaea6b9ddf88Test
https://doi.org/10.1016/j.annonc.2020.04.471Test

المؤلفون: Rutger H. T. Koornstra, Sandrine Marreaud, Victoria Atkinson, Andrey Meshcheryakov, Christian U. Blank, Piotr Rutkowski, Jean-Jacques Grob, Leonel Hernandez-Aya, Clemens Krepler, Michal Kicinski, Dirk Schadendorf, Paolo A. Ascierto, Caroline Robert, Mario Mandalà, Susana Puig, Nageatte Ibrahim, Alexander C.J. van Akkooi, Adnan Khattak, Stéphane Dalle, Georgina V. Long, James Larkin, Shahneen Sandhu, Rahima Jamal, Matteo S. Carlino, Alfonsus J M van den Eertwegh, Ralf Gutzmer, Anna Maria Di Giacomo, Andrew Haydon, Alexander M.M. Eggermont, Stefan Suciu, Paul Lorigan

المساهمون: CCA - Cancer Treatment and quality of life, Medical oncology

المصدر: Journal of Clinical Oncology, 38, 3925-3936
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, di Giacomo, A M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P C, van Akkooi, A C J, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2020, ' Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial ', Journal of Clinical Oncology, vol. 38, no. 33, pp. 3925-3936 . https://doi.org/10.1200/JCO.20.02110Test
Journal of Clinical Oncology, 38(33), 3925-3936. American Society of Clinical Oncology
Journal of Clinical Oncology
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, A M, van den Eertwegh, A J M, Grob, J J, Gutzmer, R, Jamal, R, Lorigan, P C, van Akkooi, A C J, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2020, ' Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma : Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, no. 33, pp. 3925-3936 . https://doi.org/10.1200/JCO.20.02110Test
Journal of Clinical Oncology, 38, 33, pp. 3925-3936

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Medizin, Pembrolizumab, Placebo, law.invention, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Original Reports, medicine, Stage III melanoma, Melanoma, Chemotherapy, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Cancer, medicine.disease, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, business, Adjuvant

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c8d8800862ec580f808001677c9a85Test
https://hdl.handle.net/2066/228545Test

المؤلفون: Michele W.L. Teng, Michael A. Postow, Reinhard Dummer, Claus Garbe, Paolo A. Ascierto, Christian U. Blank, Iman Osman, Michelle Krogsgaard, Patrick Hwu, Magdalena Thurin, Bernard A. Fox, Soldano Ferrone, Thomas F. Gajewski, Marc S. Ernstoff, Bart Neyns, Sergio A. Quezada, Igor Puzanov, Pawel Kalinski, Jason J. Luke, Roger S. Lo, Corrado Caracò, A. Testori, Giorgio Trinchieri

المساهمون: Clinical sciences, Medical Oncology, Laboratory of Molecular and Medical Oncology, University of Zurich, Ascierto, Paolo A

المصدر: Journal of Translational Medicine
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-18 (2021)

مصطلحات موضوعية: 0301 basic medicine, Oncology, BRAF inhibitor, medicine.medical_specialty, medicine.medical_treatment, 610 Medicine & health, Genetics and Molecular Biology, Translational research, Meeting Report, Anti-CTLA-4, Target therapy, General Biochemistry, Genetics and Molecular Biology, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, 1300 General Biochemistry, Genetics and Molecular Biology, Internal medicine, medicine, Melanoma, Adjuvant, Combination strategies, Tumor microenvironment, MEK inhibitor, business.industry, 10177 Dermatology Clinic, General Medicine, medicine.disease, Precision medicine, Immune checkpoint, Anti-PD-1, 030104 developmental biology, 030220 oncology & carcinogenesis, General Biochemistry, oncology, Biomarker (medicine), Medicine, Immunotherapy, Neoadjuvant, business, Biomarkers

وصف الملف: 910_Ascierto_PA._et_al._Perspectives_in_Melanoma_meeting_report_from_the_Melanoma_Bridge_(December_3rd-5th,_2020,_Italy)_J_Transl_Med_2021.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::728ae34e331a3034551bf810df26f0f3Test
http://europepmc.org/articles/PMC8243582Test

المؤلفون: B.A. van de Wiel, Charlotte L. Zuur, Serigne Lo, Michel W.J.M. Wouters, Carolien Bierman, María Jesús González González, Elena Shklovskaya, Christian U. Blank, Willem M.C. Klop, Elisa A. Rozeman, Robert V. Rawson, J.B.A.G. Haanen, Omgo E. Nieweg, James S. Wilmott, Andrew J. Spillane, Robyn P. M. Saw, J.V. van Thienen, C. Adhikari, Sydney Ch'ng, A.C.J. van Akkooi, Michael T. Tetzlaff, Hanna Eriksson, Helen Rizos, Alexander Guminski, Richard A. Scolyer, Kerwin F. Shannon, W.J. van Houdt, Jonathan R. Stretch, Georgina V. Long, A.M. Menzies

المصدر: Annals of Oncology, 32(6), 766-777. ELSEVIER

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Ipilimumab, 03 medical and health sciences, 0302 clinical medicine, Fibrosis, Internal medicine, medicine, Humans, Melanoma, Pathological, Lymph node, business.industry, neoadjuvant, Reproducibility of Results, Hematology, Immunotherapy, medicine.disease, Neoadjuvant Therapy, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Biomarker (medicine), immunotherapy, Nivolumab, business, pathological response, medicine.drug, metastatic melanoma

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffb61a837c13200f2514a9ed7c1f22afTest
https://hdl.handle.net/1887/3276136Test

المؤلفون: John B. A. G. Haanen, Kees Hendricksen, Axel Bex, Patricia J. Zondervan, Teele Kuusk, Niels M. Graafland, Johan V. Van Thienen, Sofie Wilgenbos, Christian U. Blank, Mariette Schrier, Brunolf W. Lagerveld, Jeroen Van Moorselaar

المساهمون: CCA - Cancer Treatment and quality of life, Urology, Graduate School, APH - Personalized Medicine, APH - Quality of Care

المصدر: Bex, A, Van Thienen, J V, Schrier, M, Graafland, N, Kuusk, T, Hendricksen, K, Lagerveld, B, Zondervan, P, van Moorselaar, J R A, Blank, C, Wilgenbos, S & Haanen, J 2019, ' A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX) ', Future Oncology, vol. 15, no. 19, pp. 2203-2209 . https://doi.org/10.2217/fon-2019-0111Test
Future Oncology, 15(19), 2203-2209. Future Medicine Ltd.
Future oncology (London, England), 15(19), 2203-2209. Future Medicine Ltd.

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Axitinib, medicine.medical_treatment, Antibodies, Monoclonal, Humanized, Nephrectomy, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Secondary Prevention, medicine, Humans, Carcinoma, Renal Cell, Survival rate, Neoadjuvant therapy, Aged, business.industry, Sunitinib, Standard treatment, Antibodies, Monoclonal, General Medicine, Middle Aged, medicine.disease, Neoadjuvant Therapy, 030104 developmental biology, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::369bb6ff466aca46df9eb0681ca38bf3Test
https://doi.org/10.2217/fon-2019-0111Test

المؤلفون: Jeffrey E. Gershenwald, Michael T. Tetzlaff, Peter A. Prieto, Jennifer L. McQuade, Charlotte E. Ariyan, Jonathan S. Zager, David F. McDermott, Adil Daud, Christian U. Blank, Kim Margolin, Richard A. Scolyer, Brett W. Carter, Elizabeth M. Burton, Richard D. Carvajal, Jeffrey A. Sosman, Alexander N. Shoushtari, April K.S. Salama, Scott E. Woodman, Tina J. Hieken, Vernon K. Sondak, Douglas S. Tyler, Jeffrey E. Lee, Frances C. Wright, Omid Hamid, David E. Fisher, Tanja D. de Gruijl, Miles C. Andrews, Michael C. Lowe, John M. Kirkwood, Keith T. Flaherty, Mark B. Faries, Grant A. McArthur, Dirk Schadendorf, Alexander C.J. van Akkooi, Alberto Fusi, Bart A. van de Wiel, James Larkin, Ken K. Tanabe, Jane L. Messina, Jennifer A. Wargo, Rodabe N. Amaria, Jonathan Cohen, Shaneen Sandhu, Andrew J. Spillane, Reinhard Dummer, Robert Antdbacka, Michael A. Postow, Michael D. Farwell, Céleste Lebbé, Jason J. Luke, Genevieve M. Boland, Tara C. Mitchell, David H. Lawson, Elisa A. Rozeman, Diwakar Davar, Caroline Robert, Kathryn Bollin, Ryan J. Sullivan, Michael A. Davies, Matteo S. Carlino, Isabella C. Glitza, Robyn P. M. Saw, Merrick I. Ross, Axel Hauschild, Teresa M. Petrella, Paolo A. Ascierto, Serigne Lo, Igor Puzanov, Samra Turajlic, Angela Hong, Roland L. Bassett, Keith A. Delman, Georgina V. Long, Hussein Abdul-Hassan Tawbi, Susan M. Swetter, Janis M. Taube, Alexander M.M. Eggermont, John F. Thompson, Donald A. Berry, Leslie A. Fecher, Matthew S. Block, Alexander M. Menzies, David E. Gyorki, Helen Rizos

المصدر: The Lancet Oncology. 20:e378-e389

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, medicine.medical_treatment, Translational research, Systemic therapy, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Surgical oncology, Internal medicine, medicine, Adjuvant therapy, Humans, Anal cancer, Melanoma, Neoadjuvant therapy, Clinical Trials as Topic, business.industry, Patient Selection, medicine.disease, Neoadjuvant Therapy, 030104 developmental biology, 030220 oncology & carcinogenesis, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b13f9238089793e46724c953ea8160cTest
https://doi.org/10.1016/s1470-2045Test(19)30332-8